Overview

A Safety, Tolerability and Efficacy Study in Chronic Obstructive Pulmonary Disease (COPD) Patients With QBM076.

Status:
Terminated
Trial end date:
2015-05-01
Target enrollment:
Participant gender:
Summary
This was a 2 Part study. Part 1 was a safety and tolerability study in GOLD I-III COPD patients. Part 2 was an efficacy study in GOLD I-III COPD patients.
Phase:
Phase 2
Details
Lead Sponsor:
Novartis Pharmaceuticals